EUVIMEDEUVIMED entdecken
Crossref

Enhancer hijacking HELLS promotes macrophage M2 polarization results in poor prognosis for prostate cancer patients

Lilin Wan, Yue Hou, Dongfang Jiang, Saisai Chen, Yifan Liu, Chunyan Chu, Xiaoying Wei, Minhao Zhang, Zhong Lv, Bin Xu, Chuanjun Shu

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-02 · 1872 (2) · 168091

DOI: 10.1016/j.bbadis.2025.168091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-02. Verfasst von Lilin Wan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Macrophages, Enhancer Elements, Genetic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer genome frequently carry large-scale somatic structural variations (SVs). The altered 3D genome structure has been identified as a potential mechanism for oncogene activation. Recently, it has been reported that enhancer hijacking events are involved in cancer progress. However, the underlying regulatory effect of non-coding large-scale somatic SVs on proto-oncogene activation in prostate cancer (PCa) remain unclear. Here, we screened enhancer hijacking events in PCa and validated them using CRISPR knockout and fluorescence in situ hybridization experiments. The functional roles of these events in PCa were investigated through cell proliferation analysis, wound-healing assay, Transwell assay, flow cytometry, immunohistochemical staining, animal experiment and bioinformatics analysis. HELLS was identified not only as a prognosis-related gene in PCa but also due to its involvement in an enhancer-hijacking event. The enhancer hijacking drives ectopic expression of HELLS, which promotes malignant phenotype of PCa cells, such as cell proliferation and migration. Meanwhile, HELLS expression levels were positively correlated with tumor neoantigen and mutation burden, Gleason score, pathological stage (T and N stage), prostate-specific antigen (PSA), and neural/vascular invasion in PCa patients. Moreover, HELLS expression varied across immune subtypes in PCa tissues, with particularly high expression in macrophages. Compared to para-cancerous or prostate hyperplasia tissues, HELLS was highly expressed in PCa tissues. It was especially highly expressed in the nucleus of M2 macrophages and co-expressed with M2 macrophage marker CD163 in PCa tissues. Furthermore, enhancer hijacking of HELLS promotes immune infiltration levels and macrophage M2 polarization in PCa. Hence, our findings indicated that enhancer hijacking drives ectopic expression of HELLS, which promotes macrophage M2 polarization, resulting in PCa progression. The hijacked enhancer for HELLS could serve as a novel early genetic indicator for PCa patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMacrophagesEnhancer Elements, GeneticMaleHumansPrognosisProto-Oncogene MasCell ProliferationCell Line, TumorAnimalsGene Expression Regulation, NeoplasticMiceCell Movement

Stichwörter der Autor:innen

Enhancer hijackingHELLSMacrophage M2 polarizationMalignant phenotypeProstate cancer

Substanzen

MAS1 protein, humanProto-Oncogene Mas

Autor:innen und Institutionen

  • Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
  • Military Medical Innovation Center, Fourth Military Medical University, Xi'an, 710032, China.
  • Department of Urology, The People's Hospital of Danyang, Danyang, Jiangsu, 212300, China.
  • Department of Pathology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.
  • Department of Urology, XiShan People's Hospital of Wuxi City, Wuxi, China. Electronic address: zmhjj1981@163.com.
  • Department of Urology, Changzhou Wujin People's Hospital, Changzhou 213003, China. Electronic address: lzabc0105@163.com.

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Wan, L., Hou, Y., Jiang, D., Chen, S., Liu, Y., Chu, C., Wei, X., Zhang, M., Lv, Z., Xu, B., & Shu, C. (2026). Enhancer hijacking HELLS promotes macrophage M2 polarization results in poor prognosis for prostate cancer patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(2), 168091. https://doi.org/10.1016/j.bbadis.2025.168091

Vancouver

Wan L, Hou Y, Jiang D, Chen S, Liu Y, Chu C, et al. Enhancer hijacking HELLS promotes macrophage M2 polarization results in poor prognosis for prostate cancer patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(2):168091. doi:10.1016/j.bbadis.2025.168091

BibTeX
@article{Wan2026,
  author = {Wan, Lilin and Hou, Yue and Jiang, Dongfang and Chen, Saisai and Liu, Yifan and Chu, Chunyan and Wei, Xiaoying and Zhang, Minhao and Lv, Zhong and Xu, Bin and Shu, Chuanjun},
  title = {Enhancer hijacking HELLS promotes macrophage M2 polarization results in poor prognosis for prostate cancer patients},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2026},
  volume = {1872},
  number = {2},
  pages = {168091},
  doi = {10.1016/j.bbadis.2025.168091}
}
Kostenlos starten →